Raffaella Fittipaldi

618 total citations
9 papers, 473 citations indexed

About

Raffaella Fittipaldi is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Raffaella Fittipaldi has authored 9 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Surgery. Recurrent topics in Raffaella Fittipaldi's work include Epigenetics and DNA Methylation (4 papers), Ubiquitin and proteasome pathways (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Raffaella Fittipaldi is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Ubiquitin and proteasome pathways (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Raffaella Fittipaldi collaborates with scholars based in Italy, United States and United Kingdom. Raffaella Fittipaldi's co-authors include Giuseppina Caretti, Vittorio Sartorelli, Valentina Proserpio, Yunching Chen, Surendar Reddy Bathula, Qi Yang, Leaf Huang, James G. Ryall, Cinzia Bottino and Claudio Fenizia and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Genes & Development.

In The Last Decade

Raffaella Fittipaldi

9 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raffaella Fittipaldi Italy 7 404 61 53 49 38 9 473
Cuilan Yang China 8 260 0.6× 134 2.2× 31 0.6× 52 1.1× 50 1.3× 11 406
Jinling Tang China 8 208 0.5× 67 1.1× 28 0.5× 47 1.0× 18 0.5× 12 614
Rony Chidiac Canada 13 255 0.6× 34 0.6× 34 0.6× 59 1.2× 21 0.6× 16 420
Haihui Gu China 12 270 0.7× 65 1.1× 29 0.5× 111 2.3× 50 1.3× 26 483
Chengyu Prince United States 11 333 0.8× 55 0.9× 23 0.4× 78 1.6× 19 0.5× 20 540
Marc B. Kaye United States 4 272 0.7× 37 0.6× 17 0.3× 51 1.0× 28 0.7× 7 357
Mari Katsura Japan 9 242 0.6× 57 0.9× 15 0.3× 71 1.4× 23 0.6× 12 356
Robert A. Poolman United Kingdom 7 358 0.9× 38 0.6× 33 0.6× 99 2.0× 25 0.7× 12 439
Simona Artuso Italy 12 358 0.9× 104 1.7× 19 0.4× 83 1.7× 13 0.3× 12 514
Theo Sottero United States 4 255 0.6× 53 0.9× 12 0.2× 41 0.8× 25 0.7× 6 323

Countries citing papers authored by Raffaella Fittipaldi

Since Specialization
Citations

This map shows the geographic impact of Raffaella Fittipaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffaella Fittipaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffaella Fittipaldi more than expected).

Fields of papers citing papers by Raffaella Fittipaldi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raffaella Fittipaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffaella Fittipaldi. The network helps show where Raffaella Fittipaldi may publish in the future.

Co-authorship network of co-authors of Raffaella Fittipaldi

This figure shows the co-authorship network connecting the top 25 collaborators of Raffaella Fittipaldi. A scholar is included among the top collaborators of Raffaella Fittipaldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raffaella Fittipaldi. Raffaella Fittipaldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Fittipaldi, Raffaella, et al.. (2021). The Lysine Methylase SMYD3 Modulates Mesendodermal Commitment during Development. Cells. 10(5). 1233–1233. 4 indexed citations
2.
Segatto, Marco, Raffaella Fittipaldi, Cinzia Bottino, et al.. (2020). BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophy. Nature Communications. 11(1). 6108–6108. 41 indexed citations
3.
Fenizia, Claudio, Cinzia Bottino, Raffaella Fittipaldi, et al.. (2018). SMYD3 promotes the epithelial–mesenchymal transition in breast cancer. Nucleic Acids Research. 47(3). 1278–1293. 72 indexed citations
4.
Segatto, Marco, Raffaella Fittipaldi, Fabrizio Pin, et al.. (2017). Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival. Nature Communications. 8(1). 1707–1707. 82 indexed citations
5.
Camperi, Andrea, Fabrizio Pin, Domiziana Costamagna, et al.. (2017). Vitamin D and VDR in cancer cachexia and muscle regeneration. Oncotarget. 8(13). 21778–21793. 38 indexed citations
6.
Peserico, Alessia, Aldo Germani, Paola Sanese, et al.. (2015). A SMYD3 Small‐Molecule Inhibitor Impairing Cancer Cell Growth. Journal of Cellular Physiology. 230(10). 2447–2460. 89 indexed citations
7.
Proserpio, Valentina, Raffaella Fittipaldi, James G. Ryall, Vittorio Sartorelli, & Giuseppina Caretti. (2013). The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy. Genes & Development. 27(11). 1299–1312. 65 indexed citations
8.
Fittipaldi, Raffaella & Giuseppina Caretti. (2012). Tackling Skeletal Muscle Cells Epigenome in the Next-Generation Sequencing Era. Comparative and Functional Genomics. 2012. 1–8. 3 indexed citations
9.
Chen, Yunching, et al.. (2009). Novel Cationic Lipid That Delivers siRNA and Enhances Therapeutic Effect in Lung Cancer Cells. Molecular Pharmaceutics. 6(3). 696–705. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026